← 產業報告目錄
Beyond the Pill Market Size, Share & Trends Analysis Report By Therapeutic Area (Diabetes, Oncology, Cardiovascular Diseases, Asthma, And Others) And Offerings (Services, Monitoring, Assistance, Information, And Education), By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-21頁數 180報告編號 INSIGHTACE-54a113d620
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Across the 2025 to 2034 projection horizon, the worldwide Beyond the Pill Market is set to register a CAGR of 11.8%.
The Beyond the Pill sector involves and the shift to personalized medical care are expected to drive industry growth. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Several factors contribute to this trajectory, including heightened interest in next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Beyond the Pill Market Snapshot
Chapter 4. Global Beyond the Pill Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Therapeutic Area Estimates & Trend Analysis
5.1. by Therapeutic Area & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Therapeutic Area:
5.2.1. Diabetes
5.2.2. Oncology
5.2.3. Cardiovascular Diseases
5.2.4. Asthma
5.2.5. Others
Chapter 6. Market Segmentation 2: by Offerings Estimates & Trend Analysis
6.1. by Offerings & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Offerings:
6.2.1. Services
6.2.2. Monitoring
6.2.3. Assistance
6.2.4. Information
6.2.5. Education
Chapter 7. Beyond the Pill Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021 to 2034
7.1.2. North America Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2021 to 2034
7.1.3. North America Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by country, 2021 to 2034
7.2. Europe
7.2.1. Europe Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021 to 2034
7.2.2. Europe Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2021 to 2034
7.2.3. Europe Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by country, 2021 to 2034
7.3. Asia Pacific
7.3.1. Asia Pacific Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021 to 2034
7.3.2. Asia Pacific Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2021 to 2034
7.3.3. Asia Pacific Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by country, 2021 to 2034
7.4. Latin America
7.4.1. Latin America Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021 to 2034
7.4.2. Latin America Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2021 to 2034
7.4.3. Latin America Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by country, 2021 to 2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021 to 2034
7.5.2. Middle East & Africa Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by Offerings, 2021 to 2034
7.5.3. Middle East & Africa Beyond the Pill Market Revenue (US$ Million) Estimates and Forecasts by country, 2021 to 2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. F. Hoffmann-La Roche AG (Flatiron Health)
8.2.2. Otsuka Pharmaceuticals Co., Ltd
8.2.3. Amgen, Inc.
8.2.4. AstraZeneca Plc
8.2.5. Novartis AG
8.2.6. Sanofi S.A
8.2.7. Novo Nordisk A/S
8.2.8. Eli Lilly and Company
8.2.9. Johnson & Johnson
8.2.10. Teva Pharmaceutical Industries Ltd
8.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們